Heather Preston visits

Great to welcome Dr Heather Preston, our recently appointed Chair, to Harness Therapeutics' Cambridge site this week!

Our team shared updates on our therapeutic programs and strategic vision, while Dr Preston brought valuable insights from her extensive experience in healthcare and biotech investing.

Excited for this next chapter as we continue developing innovative treatments for patients.

#Harness #Biotech #Leadership #Huntingtonsdisease #Neurodegenerativediseases

Our programmes

Huntington's Disease

Discover more

ALS and Alzheimer's

Discover more

Our news

June 2025

Harness Therapeutics Publishes HTT CAG Repeat Sizing Methodology Code on GitHub

February 2025

Harness Therapeutics to Present Nanopore Sequencing Data for Detecting CAG Expansion in the Huntingtin Gene at CHDI Huntington’s Disease Therapeutics Conference

January 2025

Harness Therapeutics appoints Dr Heather Preston as Chair and secures new funding from Ono Venture Investment to accelerate delivery of transformational neurodegeneration pipeline

September 2024

Harness Therapeutics Appoints Experienced R&D Executive and Physician-Scientist, Dr Paulo Fontoura, as Non-Executive Director

View all